Join global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices. Live: Wednesday, Sept. 9, 2020 at 9am EDT | 2pm BST | 3pm CEST On demand available after final airing until Sept. 9, 2021
Register free: http://www.biopharminternational.com/bp_w/leachables
Event Overview:
Join global industry and regulatory experts as they discuss E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices. Extractables and leachables are important considerations in the production of medical devices and medicinal products. While COVID-19 is around, new ventilators and delivery devices for vaccines require urgent testing. This conference offers insight into this ever-changing world of E&L.
Key Learning Objectives:
Speakers: Andrew Feilden, European E&L Strategic Director, Hall Analytical
Ron Brown, Toxicologist, Risk Science Consortium
Charles Johnson, Chemist, Bibra
Philip Clay, Director and Principal Toxicologist, Chorley Consulting
Mike Hodgson, Analytical Scientist, Baxter
Andy Teasdale, Analytical Chemist, AstraZeneca
Time and Date: Wednesday, Sept. 9, 2020 at 9am EDT | 2pm BST | 3pm CEST
On demand available after final airing until Sept. 9, 2021.
Sponsors: Hall Analytical
VR Analytical
Register free: http://www.biopharminternational.com/bp_w/leachables